Qatar Sovereign Wealth Fund invest $2.46 billion in prime Singapore location

Opportunities to penetrate the Southeast Asian real estate market are few and far between. An incredibly coveted asset, the market is traditionally dominated by domestic investors, who themselves are looking to diversify portfolios elsewhere. With incredible demand, a fantastic rate of return, and lavish opportunity, it will come as no surprise that Middle Eastern investors…

1.2 billion USD Chinese venture capital fund will invest in Indian tech startups

Chinese overseas investment has recently begun to branch out from their traditional preferred sectors – energy, real estate and infrastructure – and into a variety of other sectors, including technology. Chinese investors have recently turned their attention to Indian startups and the Indian tech sector. According to Jessica Wong, investment director at mobile advertising firm…

8.2 billion USD Chinese conglomerate plans investments into US healthcare ventures

China based conglomerate AUX Group has announced plans to seek health services investments in the US and Britain, according to recent reports. The company has 8.2 billion USD in total assets and was named among China’s top 500 enterprises. The announcement comes after AUX Group’s planned 2.7 billion AUD investment into Healthscope, the second-largest operator…

China based Tsinghua discloses multiple-billion USD stake in Silicon Valley company

Tech companies around the world are among the many businesses benefiting from the recent flood of Chinese overseas direct investment. Tsinghua Holdings, a Chinese state-owned company, has recently disclosed an investment in Marvell Technology Group, a chip maker based in Silicon Valley. Although the size of the investment has not been specified, Tsinghua reported the…

Chinese company acquires UK healthcare venture for 1.1 billion USD

In May 2016, Chinese investment group Creat Group agreed to acquire UK-based Bio Products Laboratory for 820 million GBP (1.1 billion USD). Headquartered in Hertfordshire, Bio Products Laboratory is a plasma biotherapeutics company that provides therapeutics for conditions related to bleeding disorders, immune deficiencies and critical care. Creat will invest an additional 100 million GBP…

Chinese investor makes multi-million dollar bid for French pharma company

Chinese investors specializing in healthcare are increasingly expanding into the European market with a series of high-profile, strategic investments. This is part of a trend of heightened healthcare deal activity from Chinese investors. Last year, companies based in China announced acquisitions in the medical industry worth 30.4 billion USD – representing twice the investment level…